Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.

The British journal of nutrition - 28 Jan 2016

Deschasaux Mélanie, Souberbielle Jean-Claude, Latino-Martel Paule, Sutton Angela, Charnaux Nathalie, Druesne-Pecollo Nathalie, Galan Pilar, Hercberg Serge, Le Clerc Sigrid, Kesse-Guyot Emmanuelle, Ezzedine Khaled, Touvier Mathilde

Abstract excerpt

Mechanistic hypotheses suggest that vitamin D and the closely related parathyroid hormone (PTH) may be involved in prostate carcinogenesis. However, epidemiological evidence is lacking for PTH and inconsistent for vitamin D. Our objectives were to prospectively investigate the association between vitamin D status, vitamin D-related gene polymorphisms, PTH and prostate cancer risk. A total of 129 cases diagnosed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Parathyroid Hormone

Share to Placebos

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Share to Retinoid X Receptors

Share to Vitamin D

Source

Identifiers

PMID: 26568368
DOI: 10.1017/S0007114515004353

Genes

PTH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.PMID 26568368Read ↗

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.Semantic proximity Read ↗

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.Semantic proximity Read ↗

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.Semantic proximity Read ↗

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate CancerSemantic proximity Read ↗

Vitamin D pathway gene variants and prostate cancer risk.Semantic proximity Read ↗

Association of prostate cancer with vitamin D receptor gene polymorphism.Semantic proximity Read ↗

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and prostate cancer.Semantic proximity Read ↗

Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.Semantic proximity Read ↗

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.